Cambridge Investment Research Advisors’s Oscar Health OSCR Stock Holding History

Cambridge Investment Research Advisors’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	39,039 +16,210	+71%	+$349K	﹤0.01%	2214
2026 Q1	$262K	Sell	22,829 -5,848	-20%	-$82.4K	﹤0.01%	3407
2025 Q4	$412K	Sell	28,677 -2,765	-9%	-$47.8K	﹤0.01%	2912
2025 Q3	$595K	Buy	31,442 +8,832	+39%	+$146K	﹤0.01%	2511
2025 Q2	$485K	Buy	22,610 +10,668	+89%	+$159K	﹤0.01%	2571
2025 Q1	$157K	Buy	11,942 +660	+6%	+$9.8K	﹤0.01%	3265
2024 Q4	$152K	Buy	+11,282	New	+$182K	﹤0.01%	3251

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors's OSCR Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Oscar Health (OSCR) stake by 71% in Q2 2026, buying an estimated $349K and bringing the position to 39,039 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2214.

Cambridge Investment Research Advisors first reported a position in OSCR in Q4 2024 and has held it in 7 quarters since. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Cambridge Investment Research Advisors held 39,039 shares of Oscar Health worth $1.11M as of Q2 2026.
Cambridge Investment Research Advisors bought 16,210 Oscar Health shares in Q2 2026, an estimated $349K.
Oscar Health made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2214 holding.
Cambridge Investment Research Advisors first reported a position in Oscar Health in Q4 2024 and has held it in 7 quarters since.
402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.